Abiopharma

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung

Cellebrite anuncia su participación en próximas conferencias para inversores USA - español APAC - Thai Israel - English USA - Français MEXICO - Spanish BRAZIL - Portuguese APAC - English USA - Deutsch Japan - Japanese Korea - 한국어

Rush Street Interactive to Participate at the 21st Annual Needham Technology, Media, & Consumer Conference

Skycorp to Hold Extraordinary General Meeting

Myseum.AI to Present at 16th Annual LD Micro Invitational Conference; Picture Party Named Official Private Social Media Platform

Net Asset Value(s)

INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

Antelope Enterprise Holdings Limited Announces $190,000 in Realized Gains from its “Genius Plan” and Authorizes an $95,000 Share Repurchase Program, Validating its Sustainable Capital Recycling Framework

InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares